menu search

GNTA / Genenta to Present at Upcoming Scientific and Investor Conferences

Genenta to Present at Upcoming Scientific and Investor Conferences
MILAN, Italy and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA) a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells towards a permanent self-vaccination against cancer, will present at several upcoming scientific and investor conferences. Read More
Posted: Sep 6 2023, 07:00
Author Name: GlobeNewsWire
Views: 112477

GNTA News  

Genenta to Present at Upcoming Scientific and Investor Conferences

By GlobeNewsWire
September 6, 2023

Genenta to Present at Upcoming Scientific and Investor Conferences

MILAN, Italy and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA) a clinical-stage immuno-oncology company developin more_horizontal


Search within

Pages Search Results: